Share

Meet the new EORTC Board

The year 2024 signals the beginning of a new governing mandate. We are delighted to announce that during the General Assembly held on Friday, 28 June 2024, the new EORTC Board was appointed.

We warmly welcome four distinguished new members to our Board: Mrs Caroline Artis, the new Chair of the Audit & Finance Committee; Dr Roberto Salgado, who joins as a board member; Professor Martin van den Bent, the new Chair of the Protocol Review Committee; and Early Career Investigator, Dr Jens Lehmann.

Additionally, we are pleased to announce that Dr Etienne Brain and Dr Mieke Van Hemelrijck have been re-elected for a second term, and Dr Jean-Pierre Bizzari will now serve as Special Advisor. The rest of the board members have been renewed in their current roles.

The full new Board will convene for the first time in September. The current President, Professor W. van der Graaf, will remain in position until June 2026, as approved by the General Assembly, ensuring continuity during the recent changes in the EORTC’s governance structure.

Back to news list

Related News

  • PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases

  • EORTC celebrates Rare Disease Day: Addressing unmet needs in rare cancers

  • First Site Activated in EORTC RENALUT Clinical Trial on Metastatic Clear Cell Renal Cell Carcinoma

  • World Cancer Day: How clinical cancer research changes lives

  • New international study shows access to patient-reported outcome data improves the consistency of the evaluation of cancer treatment adverse events

  • First Site Activated and First Patient Randomised in new brain cancer study VIGOR – EORTC‑2427‑BTG

  • EORTC and EMA, jointly with international stakeholders, have published a multistakeholder roadmap to accelerate treatment optimisation in oncology

  • New EORTC quality of life questionnaire for adolescents and young adults with cancer

  • P-Value Workshop

  • EORTC participation at ISPOR Europe 2025 conference